Market News AIOpen the app

Novartis says using AI has cut early drug discovery time from three years to about 18 to 24 months.

MarketRead the original at moomoo.com
Good for NVS

Novartis says AI shortened the time to identify a drug candidate, which could make research more efficient. No successful trials or added sales are reported, so the benefit is not yet proven beyond early research.

NVS · Novartis

AI read · Good for NVS

The AI's read

Faster discovery could help Novartis move more research ideas toward testing. AI is also helping the company choose targets, including kidney-disease targets. The report does not say any AI-found drug has succeeded in trials or brought in added sales, so the benefit is promising but not yet proven in patients or income.

Get alerts for NVS

Follow Novartis (NVS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NVS
Free on the App Store and Google Play, or on the web.